Sign in
CompletedNo phase

Epigenetic Effects on Traumatic Brain Injury Recovery

Key facts

Who runs it
University of Pittsburgh
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Completed
People taking part
401 people enrolled
Started
1 Jul 2017
Ended
31 Aug 2024
Type of study
Observational, 2 groups
Record updated
19 September 2024

Who can take part

Age
3 years to 18 years
Sex
Women and men

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • -hospitalized overnight for a non-penetrating complicated mild to severe TBI as defined by the lowest post-resuscitation Glasgow Coma Scale (GCS) score or orthopedic injury
  • Complicated mild TBI is defined as a GCS of 13-15 with neuroimaging indicating intracranial or parenchymal injury or depressed/displaced skull fracture. Moderate TBI is defined as GCS 9-12. Severe TBI is defined as GCS 3-8. Children are included in the OI group if they sustain a bone fracture, excluding to the skull or face, without any signs of head trauma or brain injury (e.g. nausea/vomiting, headache, loss of consciousness, GCS below 15 at any point)

Who cannot take part

  • documented or parent-reported history of previous TBI/concussion requiring overnight hospitalization
  • pre-injury neurological disorder or intellectual disability
  • pre-injury psychiatric disorder requiring hospitalization
  • sensory or motor impairment precluding study measure completion
  • non-English-speaking child or non-English-speaking parents/guardians
  • pregnancy at the time of study participation
  • participants are also excluded if at least one biosample is not able to be collected within 7 days of the injury

Where in United States

  • UPMC Children's Hospital of PittsburghPittsburgh, United States

About the trial

What the trial wants to find out

Methylation of the brain-derived neurotrophic factor (BDNF) gene is involved in both the biological encoding of childhood adversity and neuroplasticity following traumatic brain injury (TBI). This research will characterize BDNF methylation during recovery from TBI in children and investigate this novel biomarker as a potential biological mechanism underlying the known association between childhood adversity and poorer neurobehavioral outcomes following TBI in childhood. Findings from this research will contribute to an improved understanding of why some children display good recovery following TBI, whereas many others suffer from chronic neurobehavioral impairments.

The 2 groups in the trial

  • traumatic brain injury

    Children with traumatic brain injury

  • orthopedic injury

    Children with orthopedic injury

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Epigegenetic Influences on Neurobehavioral Recovery Following Pediatric Traumatic Brain Injury
Publications
Record updated
19 September 2024